Markets:

Overview

News

Currencies

International

Treasuries

Geron Corporation - Common Stock (NQ:GERN)

1.130 +0.010 (+0.89%)

Streaming Delayed Price Updated: 10:41 AM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Geron Corporation - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs ↗

June 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

28 Stocks Moving in Friday's Pre-Market Session ↗

June 18, 2021

Gainers CAI International, Inc. (NYSE: CAI) rose 45.1% to $55.35 in pre-market trading after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Geron...

Via Benzinga

Earnings Scheduled For May 10, 2021 ↗

May 10, 2021

Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...

Via Benzinga

Geron Stock Trading Is Higher On Reinforcing Imetelstat's Approach For Myelofibrosis Treatment, With Data Publication In Journal ↗

June 18, 2021

Geron Corporation (NASDAQ: GERN) stock is trading higher during the premarket in reaction to data publication from the IMbark Phase 2 trial of imetelstat for...

Via Benzinga

Geron Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology

June 17, 2021

From Geron Corporation

Via Business Wire

Geron Reports Two Presentations at Virtual European Hematology Association Annual Congress

June 14, 2021

From Geron Corporation

Via Business Wire

Geron: Return On Capital Employed Insights ↗

June 08, 2021

During Q1, Geron's (NASDAQ:GERN) reported sales totaled $137.00 thousand. Despite a 22.3% in earnings, the company posted a loss of $28.45 million. In Q4, Geron brought in $50.00...

Via Benzinga

Geron Announces Two Presentations at Upcoming European Hematology Association Annual Congress

May 12, 2021

From Geron Corporation

Via Business Wire

Geron (GERN) Q1 2021 Earnings Call Transcript ↗

May 11, 2021

GERN earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Geron: Q1 Earnings Insights ↗

May 10, 2021

Shares of Geron (NASDAQ:GERN) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 12.50% over the past year to ($0.09),...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 10, 2021

Gainers Vir Biotechnology (NASDAQ:VIR) sha...

Via Benzinga

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗

May 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...

Via Benzinga

Geron Corporation Reports First Quarter 2021 Financial Results and Recent Highlights

May 10, 2021

From Geron Corporation

Via Business Wire

Geron to Announce First Quarter 2021 Financial Results on May 10, 2021

May 03, 2021

From Geron Corporation

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 23, 2021

Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 11.8% to $1.61 during Friday's pre-market session. The market value of their outstanding shares is at $205....

Via Benzinga

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 22, 2021

From Geron Corporation

Via Business Wire

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

Geron Investors Who Have Held Their Stock Continuously Since At Least March 2018 - Kehoe Law Firm, P.C. Investigation

April 20, 2021

Investigation To Determine Whether Certain Officers And/Or Directors Of Geron Corporation Breached Their Fiduciary Duties

Via EIN Presswire

Topics Fraud

Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis

April 13, 2021

From Geron Corporation

Via Business Wire

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Geron Corporation - Common Stock (NQ:GERN)

All News about Geron Corporation - Common Stock

Starting at $3.75/week.

Subscribe Today